Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit growth in Established ...
Management expects the first quarter of fiscal 2026 to be transitional, reflecting challenging sales comparisons, tariff-related costs, and moderating consumer sentiment. Drabik described expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback